Archon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orion Group Holdings
ORN
|
+$2.4M |
| 2 |
PBPB
Potbelly
PBPB
|
+$2.21M |
| 3 |
Leonardo DRS
DRS
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$15.7M |
| 2 |
Ezcorp Inc
EZPW
|
+$9.36M |
| 3 |
Zoom
ZM
|
+$9.01M |
| 4 |
KORU Medical Systems
KRMD
|
+$6.64M |
| 5 |
Accuray
ARAY
|
+$6.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.8% |
| 2 | Technology | 17.98% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Industrials | 8.77% |
| 5 | Financials | 7.7% |
Similar funds
Archon Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Archon Capital Management held 37 positions worth $123M, down 57% from $290M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Archon Capital Management withdrew a net $141M in Q2 2024, closing 13 positions and reducing 19 holdings. Its most notable exit was Pacira BioSciences, an estimated $15.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Archon Capital Management opened a new position in Orion Group Holdings worth $2.58M.
- Archon Capital Management's largest Q2 2024 buy was Orion Group Holdings: 271,387 shares worth $2.58M.
- Archon Capital Management added most to Potbelly in Q2 2024, an estimated $2.21M increase.
- Archon Capital Management's biggest Q2 2024 reduction was Ezcorp Inc, cutting an estimated $9.36M.
- Archon Capital Management fully exited Pacira BioSciences in Q2 2024, selling an estimated $15.7M.
- Archon Capital Management's ten largest holdings make up 76% of its $123M portfolio in Q2 2024.
- Archon Capital Management opened 4 new positions and closed 13 in Q2 2024.
- Archon Capital Management's portfolio value fell 57% quarter-over-quarter to $123M.
Based on Archon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.